Can CYP1A2 help with weight loss?

The claim that CYP1A2 can aid weight loss is weakly supported by science. CYP1A2 is a gene that influences caffeine metabolism. Some DNA tests suggest that 'slow' caffeine metabolizers (CYP1A2*1F variants) respond differently to caffeine, potentially affecting fat oxidation. However, evidence is limited: GWAS studies link CYP1A2 variants to caffeine intake, but no randomized controlled trials show that CYP1A2-guided diets lead to greater weight loss than standard calorie restriction and exercise. The effect size is small and overshadowed by lifestyle factors. Additionally, high caffeine intake can cause side effects like insomnia, palpitations, or gastric irritation. Marketing of such tests as 'metabolism analysis' is often exaggerated. Conclusion: CYP1A2 alone does not help with weight loss; a calorie deficit and regular physical activity are essential. The evidence is at the GWAS level, not clinically validated.